Sort
21,281 grants matching “influenza”
Tissue factor-dependent coagulation in thrombosis and immune responses
$933,000Nigel Mackman · Univ Of North Carolina Chapel Hill · R35 · FY2025 · HL
University of Rochester Vaccine and Treatment Evaluation Unit (VTEU)
$932,430Ann R Falsey · University Of Rochester · UM1 · FY2024 · AI
Generation of Robust Resident Memory T cells in Barrier Tissues through Skin Vaccination
$931,983Thomas S. Kupper · Brigham And Women'S Hospital · R01 · FY2021 · AI
Generation of Robust Resident Memory T cells in Barrier Tissues through Skin Vaccination
$931,983Thomas S. Kupper · Brigham And Women'S Hospital · R01 · FY2020 · AI
Integrated System for Rapid Detection of Respiratory Pathogens
$931,429Michael J Lochhead · Mbio Diagnostics, Inc. · R01 · FY2015 · AI
PANDAA for universal, pan-lineage molecular detection of filoviruses to enable rapid epidemic response.
$931,246Iain James Macleod · Aldatu Biosciences, Inc. · R44 · FY2023 · AI
NYC Center of Excellence for Public Health Informatics
$930,959George M. Hripcsak · New York City Health/Mental Hygiene · P01 · FY2008 · CD
Development of novel immunotherapy for influenza virus infection
$929,766Kazue Takahashi · Massachusetts General Hospital · U01 · FY2011 · AI
Prenatal Factors and Risk of Schizophrenia in a Finnish National Birth Cohort
$929,248Alan Stewart Brown · New York State Psychiatric Institute Dba Research Foundation For Mental Hygiene, Inc · R01 · FY2009 · MH
Tomotherapy and Hematopoietic Stem Cells For Tolerance to Kidney Transplants
$928,696Dixon B Kaufman · University Of Wisconsin-Madison · U01 · FY2016 · AI
HIV neutralization and mechanisms of cellular entry
$928,538Sriram Subramaniam · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Role of Microbiome in Neonatal Lung Maturation and Immune Susceptibility
$928,370Lisa A Miller · University Of California At Davis · R01 · FY2018 · AI
Lung-on-a-Chip Disease Models for Efficacy Testing (COVID-19 Competitive Revision)
$928,351Donald E Ingber · Harvard University · UH3 · FY2020 · HL
Viral Vector Core
$928,308Jerrel L Yakel · National Institute Of Environmental Health Sciences · ZIC · FY2019 · ES
7HP349, an oral integrin activator to augment effectiveness of pre-exposure influenza vaccination
$928,224Upendra Marathi · 7 Hills Pharma, Llc · R44 · FY2023 · AI
High-throughput identification of antibody features for sequence-based epitope prediction
$926,998Nicholas C. Wu · University Of Illinois At Urbana-Champaign · DP2 · FY2024 · AT
Live, recombinant newcastle disease virus-based vaccine against high pri pathoge
$926,528Peter Palese · Columbia University Health Sciences · U54 · FY2010 · AI
Alterations In Pulmonary Immune Function And Host Resistance In COX Null Mice
$925,678Darryl C Zeldin · National Institute Of Environmental Health Sciences · ZIA · FY2024 · ES
Surveillance/Response to Avian Flu/Pandemic Influenza
$925,000Pablo Kuri · Mexico National Institute Of Public Hlth · U51 · FY2006 · CI
DEVELOPMENT OF INFLUENZA SURVEILLANCE NETWORKS
$925,000Remigio M Olveda · Research Institute For Tropical Medicine · U50 · FY2006 · CI
DEVELOPMENT OF INFLUENZA SURVEILLANCE NETWORKS
$925,000Pagbajabyn Nymadawa · Ministry Of Health Mongolia · U50 · FY2006 · CI
Genetic Investigation of Covid 19 in Lung Disease
$922,822Mark L Kahn · University Of Pennsylvania · R01 · FY2022 · HL
Dissecting Polyclonal Sera to Reveal Correlates of Productive Immune Responses to HIV
$921,938Andrew Barrett Ward · Scripps Research Institute, The · R01 · FY2020 · AI
Dissecting Polyclonal Sera to Reveal Correlates of Productive Immune Responses to HIV
$920,476Andrew Barrett Ward · Scripps Research Institute, The · R01 · FY2019 · AI
Core 2: BSL-3 Practices Core
$920,265Scott Alderman · Duke University · UC7 · FY2023 · AI